Raymond James Trust’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,434
Closed -$386K 1157
2022
Q3
$386K Buy
4,434
+441
+11% +$46.3K 0.01% 679
2022
Q2
$455K Buy
3,993
+112
+3% +$12.9K 0.02% 619
2022
Q1
$503K Buy
3,881
+382
+11% +$55.1K 0.02% 644
2021
Q4
$632K Sell
3,499
-22
-0.6% -$3.82K 0.02% 564
2021
Q3
$523K Buy
3,521
+513
+17% +$78.6K 0.02% 601
2021
Q2
$456K Sell
3,008
-120
-4% -$16.7K 0.02% 645
2021
Q1
$406K Buy
3,128
+1,209
+63% +$155K 0.01% 678
2020
Q4
$230K Buy
+1,919
New +$188K 0.01% 899

Other funds holding OMCL

Raymond James Trust's OMCL Position: Q4 2022 in Review

Raymond James Trust sold out of Omnicell (OMCL) in Q4 2022, closing a stake of 4,434 shares — an estimated $386K sold.

Raymond James Trust first reported a position in OMCL in Q4 2020 and held it in 8 quarters. The position peaked at $632K in Q4 2021. 329 funds tracked by Wall St. Rank hold OMCL as of Q4 2022.

  • Raymond James Trust reported no remaining Omnicell position as of Q4 2022 after selling out during the quarter.
  • Raymond James Trust sold 4,434 Omnicell shares in Q4 2022, an estimated $386K.
  • Raymond James Trust first reported a position in Omnicell in Q4 2020 and held it in 8 quarters.
  • Raymond James Trust's Omnicell position peaked at $632K in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Omnicell as of Q4 2022.

Based on Raymond James Trust's 13F filing for Q4 2022, filed 2 Feb 2023.